nonalcoholic fatty liver disease
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: From January 2015 to May 2022, 50 patients with pathologically confirmed NAFLD were enrolled at a single center in Japan.
Exclusion criteria
Exclusion criteria: Patients with a type of cancer other than hepatocellular carcinoma (HCC) were excluded.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The endpoint was to evaluate the influence of NAS and fibrosis to the hepatic M2BP expression | — |
Countries
Japan
Contacts
Kitasato University School of Medicine Department of Gastroenterology